Akso Health Group operates a social e-commerce platform principally in China that collaborates with other domestic e-commerce platforms and offers users a wide selection of products. The company is headquartered in Qingdao, Shandong and currently employs 27 full-time employees. The company went IPO on 2017-11-03. The firm provides services through the Xiaobai Maimai application (APP), a one-stop e-commerce platform. The firm provides products covering food and beverage, wine, cosmetic products, fashion and apparel, entertainment, houseware, home appliances and others. The firm is also engaged in social e-commerce platform business, cancer therapy and radiotherapy oncology service provider business, and the sale of coronavirus disease 2019 (COVID-19) Rapid Antigen Tests.
最新の財務諸表(Form-10K)によると、Akso Health Groupの総資産は$214で、純損失は$-134です。
AHGの主要な財務比率は何ですか?
Akso Health Groupの流動比率は14.26、純利益率は-957.14、1株当たり売上高は$0.01です。
Akso Health Groupの収益はセグメントまたは地域別にどのように分けられていますか?
Akso Health Group の最大収益セグメントは Medical Devices で、最新の利益発表における収益は 2,414,338 です。地域別に見ると、China and United States が Akso Health Group の主要市場であり、収益は 2,414,338 です。